Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On Medicinal Products With The Active Ingredient Flupentixol (atc Code: N05af01)
Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V On Drugs With The Active Ingredient Lamivudine, Tenofovir Disoproxil And Doravirine (j05ar24) As Part Of An Open-hou
Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V On Drugs With The Active Ingredient Tobramycin (j01gb01) As Part Of A So-called Open-house Model.
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Substance Dimethyl Fumarate, Atc L04ax07, For The Period 06/01/2022 - 05/31/2024
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Medicinal Products With The Active Ingredient Combination Of Vilanterol And Fluticasone Furoate (atc Code: R03a
Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On Medicinal Products With The Active Ingredient Enoxaparin (atc Code: B01ab05)